Početna › Rak (sve vrste) › Alabama
Kliničke studije za Rak (sve vrste) u državi Alabama
36 studija za Rak (sve vrste) traži sudionike na lokacijama u državi Alabama.
Gradovi u državi Alabama
Službeni tekst studije (engleski)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- UAB Medicine - UAB Hospital, Birmingham
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
U tijeku regrutacijaFaza 3
Od 18 do 71 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
U tijeku regrutacijaFaza 2
Od 12 godina i više · Oba spola · Ažurirano 22. ruj 2026. · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Alabama Birmingham, Birmingham
U tijeku regrutacijaFaza 2/3
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT07002034A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- The University of Alabama at Birmingham ( Site 1005), Birmingham
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 10. ruj 2026. · NCT06818643A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 8. ruj 2026. · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
U tijeku regrutacijaFaza 1
36 Months – 22 Years · Oba spola · Ažurirano 4. ruj 2026. · NCT03911388Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
U tijeku regrutacijaOpažajna studija
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Childrens Hospital of Alabama, Birmingham
U tijeku regrutacijaFaza 2
Od 1 do 39 godina · Oba spola · Ažurirano 7. kol 2026. · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 004, Birmingham
U tijeku regrutacijaFaza 2
Od 18 godina i više · Žene · Ažurirano 16. srp 2026. · NCT06906341A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07023289A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT06997029A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
U tijeku regrutacija
Od 60 godina i više · Oba spola · Ažurirano 6. srp 2026. · NCT06697600A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Birmingham
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 25. lip 2026. · NCT06431594Childhood Cancer Survivor Study
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 17. lip 2026. · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
U tijeku regrutacija
Od 18 do 75 godina · Oba spola · Ažurirano 17. lip 2026. · NCT05486572Multisite Implementation of COMPRENDO
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 3. lip 2026. · NCT06055296Leading Healthy Eating and Activity Promotion Program
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 do 89 godina · Oba spola · Ažurirano 19. svi 2026. · NCT06868524Video Inspired Discussions About Ethical Outcomes in Pediatrics
- Children's of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Sve dobne skupine · Oba spola · Ažurirano 14. svi 2026. · NCT06786104I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 6. svi 2026. · NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 30. tra 2026. · NCT05297734Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 24. velj 2026. · NCT07281287TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Alabama Oncology, Birmingham
U tijeku regrutacijaOpažajna studija
Od 18 do 99 godina · Oba spola · Ažurirano 24. velj 2026. · NCT06207032Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
- The Kirklin Clinic, Birmingham
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 6. velj 2026. · NCT07197515GEMINI-NSCLC: NSCLC Biomarker Study
- Alabama Oncology, Birmingham
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. velj 2026. · NCT05236114Caris Biorepository Research Protocol
- University of South Alabama, Mobile
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 21. sij 2026. · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. lis 2025. · NCT06228326BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 15. lis 2025. · NCT06472089Making Healthy Habits Stick
- University of Alabama at Birmingham, Birmingham
U tijeku regrutacija
Od 19 godina i više · Žene · Ažurirano 1. lis 2025. · NCT06745180Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
1 Month – 89 Years · Oba spola · Ažurirano 9. stu 2022. · NCT03848962Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.